Hepatic lipidosis and ketosis are frequent metabolic disorders in dairy cows during the transition period. The 2-methyl-2-phenoxy propionic acid (MFPA) is an activator of energy metabolism. The objective of this study was to evaluate the effect of administration of MFPA 10 days prepartum to day 36 postpartum on serum lipid profile, ovarian reactivity, and milk yield. Fifty seven multiparous Holstein cows were divided into four groups. The groups 1 (n = 14) and 2 (n = 14) had body condition score (BCS) above 4; BCS of the groups 3 (n = 15) and 4 (n = 14) was between 3.25 and 3.75 at calving. The solution containing 10 mg/kg MFPA was injected intramuscularly (IM) to cows of groups 1 and 3, 10-7 days prepartum and 6 h postpartum. The groups 2 and 4 received 50 ml of 0.9% NaCl as placebo in the same way. Blood samples for serum lipid profile were collected from all cows 10 days before calving without treatment, 2 days after the first administration of MFPA and postpartum at days 2, 10, and 21 after the second administration of MFPA. At days 21, 24, 27, 30, 33, and 36 postpartum, blood samples were obtained for plasma progesterone determination. Milk yield was registered daily during 60 days postpartum. Prepartum free fatty acids (FFA) were mildly increased without difference among all the groups (P > 0.05). b-hydroxybutyrate (BHB) was increased only at day 10 after calving in cows of group 1 treated with MFPA (P < 0.05) due to higher number of postpartum diseases. In cows from groups 3 and 4 (BCS normal), BHB was mildly increased, not indicating subclinical ketosis. The serum concentrations of triacylgycerols, cholesterol, albumin, activities of aspartate aminotransferase and creatine kinase were within the limits of reference values, indicating adequate liver integrity and function. Cows of normal BCS treated with MFPA presented better milk production but without significant difference among four groups (P > 0.05). Ovarian reactivity was present at day 21 in all groups of cows without difference (P > 0.05). The administration of MFPA had no effect on serum lipid profile and ovarian activity in this study.
Parturient paresis and subclinical hypocalcemia are frequent metabolic disorders in dairy cows postpartum. The aim of this study was to determine the effect of postpartum partial milking in the first two milkings on blood serum calcium concentration in dairy cows. Twenty multiparous Holstein dairy cows were randomized into two groups. Cows of group 1 (n = 10) were partially milked at the first and second milking postpartum. Cows of group 2 (n = 10) were completely milked. Blood samples were collected from all animals 5-7 days before calving, within 30 min after calving, and 4, 8, 12, 16, 20, 24, 28, and 32 h after calving for determination of serum calcium (Ca), phosphorus (P), and magnesium (Mg) concentrations. Colostrum production was registered and sampled in the first and second milking. Concentration of Ca in colostrum was determined by atomic absorption spectrophotometry. Serum Ca and P concentrations decreased in both groups after parturition (P < 0.05) and remained low during 32 h postpartum with no difference observed between groups (P > 0.05). Serum concentrations of Mg were stable in all samples and no statistical difference was observed between groups (P > 0.05). Colostrum production was higher in completely milked cows only in the first postpartum milking (P < 0.05), but there was no difference between groups at the second milking. Total Ca secretion in colostrum was higher in the complete milking group at the first and second postpartum milking. Colostrum Ca secretion increased at the second milking with respect to the first one in both groups (P < 0.05). There was no correlation between serum Ca and colostrum Ca (P > 0.05). In this study, the partial milking of colostrum in the first and second milking postpartum did not prevent subclinical hypocalcemia in dairy cows.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.